We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+3.59%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$4.43B
AUM Growth
-$11.5M
(-0.26%)
Cap. Flow
+$144M
Cap. Flow
% of AUM
3.24%
Top 10 Holdings %
Top 10 Hldgs %
37.18%
Holding
3,745
New
225
Increased
1,515
Reduced
1,175
Closed
233
Avg Time Held Equity + Options
4.6
years
Top 10 Avg Time Held Equity + Options
2.7
years
Top 20 Avg Time Held Equity + Options
3.7
years
Avg Time Held Equity only
4.6
years
Top 10 Avg Time Held Equity only
2.7
years
Top 20 Avg Time Held Equity only
3.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$39.4M |
| 2 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$26.6M |
| 3 |
CVB Financial
CVBF
|
+$17.4M |
| 4 |
Apple
AAPL
|
+$16.9M |
| 5 |
BlackRock Flexible Income ETF
BINC
|
+$15.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$25.2M |
| 2 |
iShares Investment Grade Systematic Bond ETF
IGEB
|
+$18.5M |
| 3 |
iShares US Treasury Bond ETF
GOVT
|
+$6.13M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$3.91M |
| 5 |
SS&C Technologies
SSNC
|
+$3.41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.84% |
| 2 | Technology | 15.96% |
| 3 | Healthcare | 9.75% |
| 4 | Financials | 7.52% |
| 5 | Communication Services | 4.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3276
Brandywine Realty Trust
BDN
$453M
| $357 | ﹤0.01% |
+80
| New | +$396 |
2025 Q1
0 quarters
|
|
3277
DELISTED
Enfusion, Inc.
ENFN
| $357 | ﹤0.01% |
+32
| New | +$354 |
2025 Q1
0 quarters
|
|
|
ABVE
3278
DELISTED
Above Food Ingredients Inc
ABVE
| $356 | ﹤0.01% |
600
| – | – |
2024 Q3
2 quarters
|
|
3279
Target Hospitality
TH
$1.57B
| $355 | ﹤0.01% |
+54
| New | +$433 |
2025 Q1
0 quarters
|
|
3280
NCR Voyix
VYX
$1.04B
| $351 | ﹤0.01% |
36
-102
| -74% | -$1.2K |
2016 Q4
33 quarters
|
|
3281
Protolabs
PRLB
$2.09B
| $350 | ﹤0.01% |
10
-10
| -50% | -$394 |
2019 Q3
22 quarters
|
|
3282
Bowman Consulting
BWMN
$710M
| $349 | ﹤0.01% |
+16
| New | +$373 |
2025 Q1
0 quarters
|
|
3283
Mineralys Therapeutics
MLYS
$1.91B
| $349 | ﹤0.01% |
22
| – | – |
2023 Q4
5 quarters
|
|
3284
Pangaea Logistics
PANL
$515M
| $347 | ﹤0.01% |
+73
| New | +$384 |
2025 Q1
0 quarters
|
|
3285
Aurinia Pharmaceuticals
AUPH
$2.23B
| $346 | ﹤0.01% |
43
| – | – |
2024 Q4
1 quarter
|
|
3286
DELISTED
MoneyLion Inc.
ML
| $346 | ﹤0.01% |
4
| – | – |
2024 Q4
1 quarter
|
|
3287
BrightSpring Health Services
BTSG
$12.3B
| $344 | ﹤0.01% |
19
+14
| +280% | +$275 |
2024 Q4
1 quarter
|
|
3288
Phibro Animal Health
PAHC
$1.54B
| $342 | ﹤0.01% |
+16
| New | +$358 |
2025 Q1
0 quarters
|
|
3289
Manitowoc
MTW
$809M
| $335 | ﹤0.01% |
+39
| New | +$380 |
2025 Q1
0 quarters
|
|
3290
Alarm.com
ALRM
$2.83B
| $334 | ﹤0.01% |
6
| – | – |
2024 Q4
1 quarter
|
|
3291
AGNT Inc
AGNT
$653M
| $333 | ﹤0.01% |
34
+21
| +162% | +$223 |
2021 Q3
14 quarters
|
|
3292
Cannae Holdings
CNNE
$704M
| $330 | ﹤0.01% |
18
-35
| -66% | -$660 |
2023 Q4
5 quarters
|
|
3293
Bioventus
BVS
$943M
| $329 | ﹤0.01% |
+36
| New | +$360 |
2025 Q1
0 quarters
|
|
3294
AdvisorShares Focused Equity ETF
CWS
$121M
| $327 | ﹤0.01% |
5
| – | – |
2024 Q3
2 quarters
|
|
3295
Innoviz Technologies
INVZ
$83.9M
| $326 | ﹤0.01% |
500
| – | – |
2023 Q3
6 quarters
|
|
3296
Avita Medical
RCEL
$415M
| $326 | ﹤0.01% |
40
| – | – |
2021 Q1
16 quarters
|
|
3297
Vitamin Cottage Natural Grocers
NGVC
$705M
| $322 | ﹤0.01% |
8
| – | – |
2024 Q3
2 quarters
|
|
3298
Weave Communications
WEAV
$595M
| $322 | ﹤0.01% |
+29
| New | +$416 |
2025 Q1
0 quarters
|
|
3299
Riley Exploration Permian
REPX
$1.04B
| $321 | ﹤0.01% |
11
| – | – |
2024 Q3
2 quarters
|
|
3300
Claros Mortgage Trust
CMTG
$166M
| $317 | ﹤0.01% |
85
-24
| -22% | -$82 |
2024 Q4
1 quarter
|
|
Similar funds
Parallel Advisors's Q1 2025 Portfolio in Review
As of Q1 2025, Parallel Advisors held 3,745 positions worth $4.43B, down 0.26% from $4.45B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Parallel Advisors deployed $144M of net new capital in Q1 2025, opening 225 new positions and adding to 1,515 existing holdings. Its largest new stake was Avantis US Large Cap Value ETF: 6,987 shares worth $456K.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, up from 47% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Palantir, an estimated $25.2M trimmed.
- Parallel Advisors's largest Q1 2025 buy was Avantis US Large Cap Value ETF: 6,987 shares worth $456K.
- Parallel Advisors added most to Microsoft in Q1 2025, an estimated $39.4M increase.
- Parallel Advisors's biggest Q1 2025 reduction was Palantir, cutting an estimated $25.2M.
- Parallel Advisors fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $2.68M.
- Parallel Advisors's ten largest holdings make up 37% of its $4.43B portfolio in Q1 2025.
- Parallel Advisors opened 225 new positions and closed 233 in Q1 2025.
- Parallel Advisors's portfolio value fell 0.26% quarter-over-quarter to $4.43B.
Based on Parallel Advisors's 13F filing for Q1 2025, filed 8 Apr 2025.